Antiretroviral Therapy in a Thousand Patients with AIDS in Haiti
Open Access
- 1 December 2005
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (22), 2325-2334
- https://doi.org/10.1056/nejmoa051908
Abstract
The one-year survival rate of adults and children with the acquired immunodeficiency syndrome (AIDS), without antiretroviral therapy, has been about 30 percent in Haiti. Antiretroviral therapy has recently become available in Haiti and in other developing countries. Data on the efficacy of antiretroviral therapy in developing countries are limited. High rates of coinfection with tropical diseases and tuberculosis, along with malnutrition and limited laboratory monitoring of therapy, may decrease the efficacy of antiretroviral therapy in these countries.Keywords
This publication has 22 references indexed in Scilit:
- Effectiveness of Antiretroviral Therapy Among Patients Who Attend Public HIV Clinics in Rio de Janeiro, BrazilJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South AfricaAIDS, 2004
- Agent and cell-type specificity in the induction of insulin resistance by HIV protease inhibitorsAIDS, 2003
- Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistanceThe Lancet, 2002
- Community-based approaches to HIV treatment in resource-poor settingsThe Lancet, 2001
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Randomised placebo-controlled trial of ritonavir in advanced HIV-1 diseaseThe Lancet, 1998
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997